July 22 - 25, 2024
Vermont Senator Bernie Sanders took another swing at the pharmaceutical industry, calling out drug companies for spending more on marketing and sales than research and development. Though drug companies tend to justify high drug prices, in part by citing investments in research and development, Sanders is not buying that argument.